Systemic delivery of AAV-GFM1 corrects COXPD1 molecular alterations in Gfm1<sup>R671C/-</sup> mice.
Overview
- Research Group on Neuromuscular and Mitochondrial Diseases, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, and Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III,Barcelona, Spain
- Institute for Bioengineering of Catalonia (IBEC),Barcelona, Spain
- Programa de Investigación de Terapia Génica de Enfermedades Raras, División de Medicina de ADN y ARN, Centro de Investigación Médica Aplicada (CIMA),Pamplona, Spain
- Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation,Barcelona, Spain
- Hospital del Mar Research Institute,Barcelona, Spain
Abstract
Hepatoencephalopathy due to mutations in the nuclear gene GFM1, known as combined oxidative phosphorylation (OXPHOS) deficiency type I (COXPD1), is an autosomal recessive mitochondrial disease caused by defects or deficiency of the mitochondrial translation elongation factor G1 (EFG1), with no currently available cure. Patients with COXPD1 develop a severe encephalopathy, sometimes combined with liver failure, with neonatal onset and rapid progression that normally causes premature death. The Gfm1R671C/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Data links
- ebi.ac.uk/
biostudies/ , EMBL-EBI; found in the notessourcedata
Data availability
This study includes no data deposited in external repositories.
The source data of this paper are collected in the following database record: biostudies:S-SCDT-10_103
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 29 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 9 authors, 1 keyword, 14 MeSH terms, 6 funders, 74 references.
Cite
This paper
Molina-Berenguer, M., Herrero-Martínez, D., Vallbona-Garcia, A., Vila-Julià, F., Cámara, Y., Vales, Á., González-Aseguinolaza, G., Torres-Torronteras, J., & Martí, R. (2026). Systemic delivery of AAV-GFM1 corrects COXPD1 molecular alterations in Gfm1&
BibTeX
@article{molinaberenguer
author = {Molina-Berenguer, Miguel and Herrero-Martínez, Diego and Vallbona-Garcia, Antoni and Vila-Julià, Ferran and Cámara, Yolanda and Vales, África and González-Aseguinolaza, Gloria and Torres-Torronteras, Javier and Martí, Ramon},
title = {{Systemic delivery of AAV-GFM1 corrects COXPD1 molecular alterations in Gfm1\&
journal = {EMBO molecular medicine},
year = {2026},
month = apr,
volume = {18},
number = {6},
pages = {2152--2179},
publisher = {Nature Publishing Group},
issn = {1757-4676},
doi = {10.1038/
url = {https://
pmid = {41998139},
pmcid = {PMC13269562}
}
RIS
TY - JOUR
AU - Molina-Berenguer, Miguel
AU - Herrero-Martínez, Diego
AU - Vallbona-Garcia, Antoni
AU - Vila-Julià, Ferran
AU - Cámara, Yolanda
AU - Vales, África
AU - González-Aseguinolaza, Gloria
AU - Torres-Torronteras, Javier
AU - Martí, Ramon
TI - Systemic delivery of AAV-GFM1 corrects COXPD1 molecular alterations in Gfm1&
T2 - EMBO molecular medicine
J2 - EMBO Mol Med
PY - 2026
DA - 2026/
VL - 18
IS - 6
SP - 2152
EP - 2179
SN - 1757-4676
PB - Nature Publishing Group
DO - 10.1038/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1038/
"type": "article-journal",
"title": "Systemic delivery of AAV-GFM1 corrects COXPD1 molecular alterations in Gfm1&
"container-title": "EMBO molecular medicine",
"author": [
{
"family": "Molina-Berenguer",
"given": "Miguel"
},
{
"family": "Herrero-Martínez",
"given": "Diego"
},
{
"family": "Vallbona-Garcia",
"given": "Antoni"
},
{
"family": "Vila-Julià",
"given": "Ferran"
},
{
"family": "Cámara",
"given": "Yolanda"
},
{
"family": "Vales",
"given": "África"
},
{
"family": "González-Aseguinolaza",
"given": "Gloria"
},
{
"family": "Torres-Torronteras",
"given": "Javier"
},
{
"family": "Martí",
"given": "Ramon"
}
],
"container-title-short":
"volume": "18",
"issue": "6",
"page": "2152-2179",
"DOI": "10.1038/
"PMID": "41998139",
"PMCID": "PMC13269562",
"ISSN": "1757-4676",
"publisher": "Nature Publishing Group",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
17
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s44321-024-00111-4
- Restoration of defective oxidative phosphorylation to a subset of neurons prevents mitochondrial encephalopathy.Journal: EMBO molecular medicineIn common: mouse, cellular / molecular, 9 references
- [2] doi:10.1038/s41598-026-38039-z [code]
- Comparison of AAV9-driven motor neuron transduction following different CNS-directed delivery methods in mice.Journal: Scientific reportsIn common: mouse, 6 references
- [3] doi:10.1016/j.omta.2026.201729
- Swine reporter model for preclinical evaluation and characterization of gene delivery vectors.Journal: Molecular therapy. AdvancesIn common: cellular / molecular, 5 references
- [4] doi:10.1016/j.medj.2022.11.002 [code]
- Systemic administration of novel engineered AAV capsids facilitates enhanced transgene expression in the macaque CNS.Journal: Med (New York, N.Y.)In common: mouse, 5 references
- [5] doi:10.26508/lsa.202503323
- Loss of PLA2G4E compromises synaptic structure and cognitive outcomes in mice.Journal: Life science allianceIn common: mouse, cellular / molecular, 1 reference, author África Vales
- [6] doi:10.1016/j.ymthe.2026.03.030 [code]
- Structural basis of liver de-targeting and neuronal tropism of CNS-targeted AAV capsids.Journal: Molecular therapy : the journal of the American Society of Gene TherapyIn common: mouse, cellular / molecular, 4 references
- [7] doi:10.1016/j.celrep.2025.116419 [code]
- AAVs targeting human carbonic anhydrase IV enhance gene delivery to the brain.Journal: Cell reportsIn common: mouse, cellular / molecular, 4 references
- [8] doi:10.1016/j.ymthe.2026.05.008
- Systemic dual-gene therapy reverses biochemical intoxication in the central metabolic compartment of Bckdha-/
- mice. Journal: Molecular therapy : the journal of the American Society of Gene TherapyIn common: mouse, 4 references - [9] doi:10.1038/s41531-026-01289-9
- Introducing PIGMO, a novel PIGmented MOuse model of Parkinson's disease.Journal: NPJ Parkinson's diseaseIn common: mouse, 3 references
- [10] doi:10.1016/j.ymthe.2024.11.023
- CRISPR targeting of mmu-miR-21a through a single adeno-associated virus vector prolongs survival of glioblastoma-bearing mice.Journal: Molecular therapy : the journal of the American Society of Gene TherapyIn common: mouse, cellular / molecular, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
